Trials / Recruiting
RecruitingNCT04680715
Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer
Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer : Faisability and Toxicity Study
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Centre Antoine Lacassagne · Academic / Other
- Sex
- Female
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
Phase II study; open recruitment, multicentrique. The aim of this clinical research is to evaluate faisability and toxicity of the per-operative radiotherapy using PAPILLON + TM device for localized breast cancers patients over 65 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Per-Operative Radiotherapy technique by Papillon +TM | 20Gy Per-Operative Radiotherapy technique by Papillon +TM, on localized breast cancer |
Timeline
- Start date
- 2021-07-16
- Primary completion
- 2027-06-01
- Completion
- 2028-06-01
- First posted
- 2020-12-23
- Last updated
- 2026-01-29
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04680715. Inclusion in this directory is not an endorsement.